Position in NAMS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$110,745,809
+$40,759,081 QoQ
Shares Held
3,267,802
+49.5% QoQ
Ownership
2.73%
of shares outstanding
% of Portfolio
1.00%
of 13F equity value
Holder Rank
#9
of 197 holders
Holding Since
Dec 2024
7 quarters on record
Common Shares in NAMS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MAVERICK CAPITAL LTD holds $942,556,118 across 15 Biotechnology names. NAMS ranks #2 (11.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
2,150,762 | $229,314,244 | |
| 2 | NAMS |
NewAmsterdam Pharma Co N.V.
This page
|
3,267,802 | $110,745,809 | |
| 3 | TECH |
BIO-TECHNE Corp
|
1,535,610 | $108,490,846 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
2,829,024 | $100,119,159 | |
| 5 | MANE |
Veradermics, Inc
|
789,980 | $97,120,141 | |
| 6 | PCVX |
Vaxcyte, Inc.
|
1,613,242 | $93,777,757 | |
| 7 | BLTE |
Belite Bio, Inc
|
396,311 | $61,025,949 | |
| 8 | WVE |
Wave Life Sciences, Inc.
|
10,278,115 | $59,715,848 |
All Filings in NAMS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $110,745,809 | 3,267,802 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $69,986,728 | 2,186,402 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $66,449,448 | 1,894,226 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $42,795,004 | 1,504,747 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $27,742,238 | 1,531,874 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $11,247,630 | 549,469 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $8,995,128 | 350,005 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||